Consultation outcome

Merger remedies

This consultation has concluded

Detail of outcome

The CMA has published its response to the consultation and issued a revised version of the merger remedies guidance for merger parties and their advisers.

Feedback received

Response to consultation

Allen Overy

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Ashurst

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Clifford Chance

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail of feedback received

The responses can be found above.


Original consultation

Summary

The CMA is consulting on its approach and requirements in the selection, design and implementation of remedies in Phase 1 and Phase 2 merger investigations.

This consultation ran from
to

Consultation description

The CMA is seeking the views of interested parties, particularly merger parties and their advisers.

Documents

Draft guidance on merger remedies

Updates to this page

Published 12 June 2018
Last updated 13 December 2018 + show all updates
  1. Responses to the consultation published, final outcome published, and link to newly published guidance added.

  2. First published.

Sign up for emails or print this page